Blackland
05-20
药完全就是太扯了,一点预期都没
翰森制药盘中异动 股价大涨3.19%报24.250港元
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":437039535739280,"tweetId":"437039535739280","gmtCreate":1747711922877,"gmtModify":1747711924826,"author":{"id":4160227637143462,"idStr":"4160227637143462","authorId":4160227637143462,"authorIdStr":"4160227637143462","name":"Blackland","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>药完全就是太扯了,一点预期都没</p></body></html>","htmlText":"<html><head></head><body><p>药完全就是太扯了,一点预期都没</p></body></html>","text":"药完全就是太扯了,一点预期都没","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/437039535739280","repostId":2536657572,"repostType":2,"repost":{"id":"2536657572","kind":"news","pubTimestamp":1747705008,"share":"https://ttm.financial/m/news/2536657572?lang=&edition=full","pubTime":"2025-05-20 09:36","market":"hk","language":"zh","title":"翰森制药盘中异动 股价大涨3.19%报24.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536657572","media":"市场透视","summary":"2025年05月20日早盘09时36分,翰森制药股票出现波动,股价急速拉升3.19%。截至发稿,该股报24.250港元/股,成交量116.36万股,换手率0.02%,振幅1.70%。资金方面,该股资金流入1297.84万港元,流出560.96万港元。翰森制药股票所在的药品行业中,整体涨幅为0.58%。其相关个股中,三生制药、兆科眼科-B、石药集团涨幅较大,振幅较大的相关个股有三生制药、兆科眼科-B、康哲药业,振幅分别为36.83%、7.44%、6.27%。","content":"<html><body><article><p>2025年05月20日早盘09时36分,<a href=\"https://laohu8.com/S/03692\">翰森制药</a>(03692.hk)股票出现波动,股价急速<span>拉升</span>3.19%。截至发稿,该股报24.250港元/股,成交量116.36万股,<span>换手率</span>0.02%,振幅1.70%。</p><p>资金方面,该股资金流入1297.84万港元,流出560.96万港元。</p><p>最近的财报数据显示,该股实现<span>营业收入</span>132.40亿港元,<span>净利润</span>47.21亿港元,<span>每股收益</span>0.80港元,<span>毛利</span>120.46亿港元,市盈率30.55倍。</p><p>机构评级方面,在所有26家参与评级的机构中,96%的券商给予买入建议,4%的券商给予持有建议,无券商给予卖出建议。</p><p>翰森制药股票所在的药品行业中,整体涨幅为0.58%。其相关个股中,<a href=\"https://laohu8.com/S/01530\">三生制药</a>、<a href=\"https://laohu8.com/S/06622\">兆科眼科-B</a>、<a href=\"https://laohu8.com/S/01093\">石药集团</a>涨幅较大,振幅较大的相关个股有三生制药、兆科眼科-B、<a href=\"https://laohu8.com/S/00867\">康哲药业</a>,振幅分别为36.83%、7.44%、6.27%。</p><p>翰森制药公司简介:翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统(CNS)疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。</p><p>(以上内容为<a href=\"https://laohu8.com/S/00700\">腾讯</a>自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>翰森制药盘中异动 股价大涨3.19%报24.250港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n翰森制药盘中异动 股价大涨3.19%报24.250港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-20 09:36 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520093648a484b57a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年05月20日早盘09时36分,翰森制药(03692.hk)股票出现波动,股价急速拉升3.19%。截至发稿,该股报24.250港元/股,成交量116.36万股,换手率0.02%,振幅1.70%。资金方面,该股资金流入1297.84万港元,流出560.96万港元。最近的财报数据显示,该股实现营业收入132.40亿港元,净利润47.21亿港元,每股收益0.80港元,毛利120.46亿港元,...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520093648a484b57a&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03692":"翰森制药","BK1191":"制药","BK1583":"高瓴概念","BK1589":"北水核心资产"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520093648a484b57a&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2536657572","content_text":"2025年05月20日早盘09时36分,翰森制药(03692.hk)股票出现波动,股价急速拉升3.19%。截至发稿,该股报24.250港元/股,成交量116.36万股,换手率0.02%,振幅1.70%。资金方面,该股资金流入1297.84万港元,流出560.96万港元。最近的财报数据显示,该股实现营业收入132.40亿港元,净利润47.21亿港元,每股收益0.80港元,毛利120.46亿港元,市盈率30.55倍。机构评级方面,在所有26家参与评级的机构中,96%的券商给予买入建议,4%的券商给予持有建议,无券商给予卖出建议。翰森制药股票所在的药品行业中,整体涨幅为0.58%。其相关个股中,三生制药、兆科眼科-B、石药集团涨幅较大,振幅较大的相关个股有三生制药、兆科眼科-B、康哲药业,振幅分别为36.83%、7.44%、6.27%。翰森制药公司简介:翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统(CNS)疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","news_type":1,"symbols_score_info":{"03692":1}},"isVote":1,"tweetType":1,"viewCount":316,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":29,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/437039535739280"}
精彩评论